Targeting in 2024: What Brands Need to Know

By: Emilie Branch, Senior Content Manager, Swoop

With 2024 planning underway, now is the time to get strategic about audiences. At its core, successful healthcare marketing starts with the target audience: who they are, where do they engage and what content they are most likely to engage with. This lively conversation with Swoop and MM+M focuses on 2024 planning, including the channels healthcare marketers are prioritizing, and how target audiences are informing that planning. Additional topics that will be covered include:

• How pharma marketers are making decisions around their target audiences and how to get the most out of them.

• What brands are doing to coordinate their DTC and HCP marketing, specifically how they seek to engage ideal patients and their associated HCPs with complementary activations.

• Opportunities to leverage AI to predict target audiences at specific, but critical points, of the diagnosis and treatment journey.

About the Author

Emilie Branch 

Senior Content Manager

Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific.